FindTrial
Sign In

Study on the expression level of serum Galectin-3 in patients with atrial fibrillation complicated with heart failure

Study on the expression level of serum Galectin-3 in patients with atrial fibrillation complicated with heart failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017340
Enrollment
Unknown
Registered
2018-07-25
Start date
2018-07-24
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with atrial fibrillation

Interventions

Case series:no

Sponsors

Central South University Xiangya Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: With a history of atrial fibrillation (including paroxysmal atrial fibrillation, persistent atrial fibrillation, and permanent atrial fibrillation) and electrocardiogram showed atrial fibrillation.

Exclusion criteria

Exclusion criteria: Cancer history, pregnancy, diabetes, moderate-to-severe valvular disease, congenital heart disease, alcohol consumption, abnormal thyroid function, kidney disease, liver disease, pulmonary fibrosis, autoimmune disease, recent infection, attempted catheter or surgical AF ablation

Design outcomes

Primary

MeasureTime frame
Galectin-3;—

Countries

China

Contacts

Public ContactXiangyu Zhang

Central South University Xiangya Second Hospital

13707486860@qq.com+86 13707486860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026